MOL CANCER RES

Publications

  1. 2023
  2. BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration

    Bady, E., Moeller, K., Mandelkow, T., Raedler, J. B., Yang, C., Ebner, J., Lurati, M. C. J., Simon, R., Vettorazzi, E., Büscheck, F., Luebke, A. M., Dum, D., Menz, A., Sauter, G., Hoeflmayer, D., Weidemann, S., Fraune, C., Uhlig, R., Bernreuther, C., Jacobsen, F., Clauditz, T. S., Wilczak, W., Burandt, E., Steurer, S., Minner, S., Lennartz, M. & Blessin, N. C., 01.06.2023, In: MOL CANCER RES. 21, 6, p. 605-613 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2020
  4. Urothelial Carcinoma of the Bladder Induces Endothelial Cell Activation and Hypercoagulation

    John, A., Robador, J. R., Vidal-Y-Sy, S., Houdek, P., Wladykowski, E., Günes, C., Bolenz, C., Schneider, S. W., Bauer, A. T. & Gorzelanny, C., 07.2020, In: MOL CANCER RES. 18, 7, p. 1099-1109 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2019
  6. CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis

    Roblek, M., Protsyuk, D., Becker, P. F., Stefanescu, C., Gorzelanny, C., Glaus Garzon, J. F., Knopfova, L., Heikenwalder, M., Luckow, B., Schneider, S. W. & Borsig, L., 03.2019, In: MOL CANCER RES. 17, 3, p. 783-793 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2018
  8. Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

    Benten, D., Behrang, Y., Unrau, L., Weissmann, V., Wolters-Eisfeld, G., Burdak-Rothkamm, S., Stahl, F. R., Anlauf, M., Grabowski, P., Möbs, M., Dieckhoff, J., Sipos, B., Fahl, M., Eggers, C., Perez, D., Bockhorn, M., Izbicki, J. R., Lohse, A. W. & Schrader, J., 01.03.2018, In: MOL CANCER RES. 16, 3, p. 496-507 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2014
  10. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer

    Rawnaq, T., Dietrich, L., Wolters-Eisfeld, G., Uzunoglu, F. G., Vashist, Y. K., Bachmann, K., Simon, R., Izbicki, J. R., Bockhorn, M. & Güngör, C., 01.05.2014, In: MOL CANCER RES. 12, 5, p. 670-80 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. 2013
  12. Expression Regulation of the Metastasis-Promoting Protein InsP3-Kinase-A in Tumor Cells.

    Chang, L., Schwarzenbach, H., Meyer-Staeckling, S., Brandt, B., Mayr, G. W., Weitzel, J. M. & Windhorst, S., 2013, In: MOL CANCER RES.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2011
  14. Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes.

    Wege, H., Heim, D., Lütgehetmann, M., Dierlamm, J., Lohse, A. W. & Brümmendorf, T. H., 2011, In: MOL CANCER RES. 9, 9, p. 1222-1231 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2007
  16. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.

    Olejniczak, E. T., Charles, V. S., Anderson, M. G., Wang, G., Tahir, S. K., Sauter, G., Lesniewski, R. & Semizarov, D., 2007, In: MOL CANCER RES. 5, 4, p. 331-339 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.

    Wischnewski, F., Friese, O., Pantel, K. & Schwarzenbach, H., 2007, In: MOL CANCER RES. 5, 7, p. 749-759 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2006
  19. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.

    Wischnewski, F., Pantel, K. & Schwarzenbach, H., 2006, In: MOL CANCER RES. 4, 5, p. 339-349 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2004
  21. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors

    Kurtz, A., Lueth, M., Kluwe, L., Zhang, T., Foster, R., Mautner, V-F., Hartmann, M., Tan, D-J., Martuza, R. L., Friedrich, R. E., Driever, P. H. & Wong, L-J. C., 01.08.2004, In: MOL CANCER RES. 2, 8, p. 433-41 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review